Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 22, 2009
The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes
A Cabré, I Lázaro, J Girona, et al.
Journal of the American College of Cardiology
|
December 1, 1993
Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment
G Sanz, A Betriu, G Oller, et al.
Coronary Artery Disease
|
February 1, 1996
The role of endogenous nitric oxide in the response of coronary blood flow to tachycardia
M Heras, E Roig, F Pérez-Villa, et al.
Revista Espanola De Cardiologia
|
November 24, 1999
[Practice guidelines of the Spanish Society of Cardiology. Recommendations for the use of antithrombotic treatment in cardiology]
M Heras, A Fernández Ortiz, J A Gómez Guindal, et al.
Heart (British Cardiac Society)
|
July 20, 2007
Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation
J Sanchis, X Bosch, V Bodí, et al.
Blood Purification
|
June 22, 2000
Hemodiafiltration with on-line endogenous reinfusion
A L de Francisco, C Piñera, M Heras, et al.
British Journal of Pharmacology
|
March 4, 2011
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
M M B Ribeiro, A Pinto, M Pinto, et al.
Circulation
|
February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin
J S Mruk, P Zoldhelyi, M W Webster, et al.
Revista Espanola De Cardiologia
|
March 4, 2000
[Effect of cyclooxygenase inhibition on the adaptation of coronary blood flow to tachycardia]
F Pérez-Villa, F Epelde, E Roig, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 29, 2016
Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk
J Merino, A Sala-Vila, N Plana, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 22, 2009
The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes
A Cabré, I Lázaro, J Girona, et al.
Journal of the American College of Cardiology
|
December 1, 1993
Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment
G Sanz, A Betriu, G Oller, et al.
Coronary Artery Disease
|
February 1, 1996
The role of endogenous nitric oxide in the response of coronary blood flow to tachycardia
M Heras, E Roig, F Pérez-Villa, et al.
Revista Espanola De Cardiologia
|
November 24, 1999
[Practice guidelines of the Spanish Society of Cardiology. Recommendations for the use of antithrombotic treatment in cardiology]
M Heras, A Fernández Ortiz, J A Gómez Guindal, et al.
Heart (British Cardiac Society)
|
July 20, 2007
Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation
J Sanchis, X Bosch, V Bodí, et al.
Blood Purification
|
June 22, 2000
Hemodiafiltration with on-line endogenous reinfusion
A L de Francisco, C Piñera, M Heras, et al.
British Journal of Pharmacology
|
March 4, 2011
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
M M B Ribeiro, A Pinto, M Pinto, et al.
Circulation
|
February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin
J S Mruk, P Zoldhelyi, M W Webster, et al.
Revista Espanola De Cardiologia
|
March 4, 2000
[Effect of cyclooxygenase inhibition on the adaptation of coronary blood flow to tachycardia]
F Pérez-Villa, F Epelde, E Roig, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
January 29, 2016
Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk
J Merino, A Sala-Vila, N Plana, et al.
Page
of 11